These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16504369)

  • 1. Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study.
    Chan J; Cabrol D; Ingemarsson I; Marsal K; Moutquin JM; Fisk NM
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):135-41. PubMed ID: 16504369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine.
    de Heus R; Mulder EJ; Derks JB; Kurver PH; van Wolfswinkel L; Visser GH
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):139-45. PubMed ID: 18316155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
    Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
    Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of atosiban and ritodrine in external cephalic version.
    Stergiotou I; Talbot F; Yoong W
    Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
    Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
    J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which tocolytic drugs in case of preterm labor?].
    Carbonne B; Tsatsaris V
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S96-104. PubMed ID: 12454631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atosiban and nifedipine in acute tocolysis: a comparative study.
    Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
    Wex J; Connolly M; Rath W
    BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Normal' pregnancy with adverse events on initial tocolytic treatment.
    Dudenhausen J
    BJOG; 2006 Dec; 113 Suppl 3():116-7. PubMed ID: 17206979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.